These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3543682)

  • 1. Primary biliary cirrhosis.
    Kaplan MM
    N Engl J Med; 1987 Feb; 316(9):521-8. PubMed ID: 3543682
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy.
    Terasaki S; Nakanuma Y; Ogino H; Unoura M; Kobayashi K
    Am J Gastroenterol; 1991 Sep; 86(9):1194-9. PubMed ID: 1882800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis.
    Dimoulios P; Kolios G; Notas G; Matrella E; Xidakis C; Koulentaki M; Tsagarakis N; Kouroumalis A; Kouroumalis E
    Aliment Pharmacol Ther; 2005 Feb; 21(3):227-34. PubMed ID: 15691296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular sensitivity to native type IV collagen in primary biliary cirrhosis.
    Suou T; Ago H; Sawada H; Hirayama C
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):275-91. PubMed ID: 8480075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic hepatitis and primary biliary liver cirrhosis with D-penicillamine].
    Mansurov KhKh; Mirodzhov GK; Ladnaia MM
    Klin Med (Mosk); 1981 Feb; 59(2):91-5. PubMed ID: 7289493
    [No Abstract]   [Full Text] [Related]  

  • 7. Open-label pilot study of tetracycline in the treatment of primary biliary cirrhosis.
    Maddala YK; Jorgensen RA; Angulo P; Lindor KD
    Am J Gastroenterol; 2004 Mar; 99(3):566-7. PubMed ID: 15056105
    [No Abstract]   [Full Text] [Related]  

  • 8. The late results of long-term treatment of primary biliary cirrhosis by corticosteroids.
    Howat HT; Ralston AJ; Varley H; Wilson JA
    Rev Int Hepatol; 1966; 16(2):227-38. PubMed ID: 5947845
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies in primary biliary cirrhosis.
    Taal BG
    Neth J Med; 1981; 24 Suppl 1():1-30. PubMed ID: 7322249
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic effects of ursodeoxycholic acid in primary biliary cirrhosis.
    Leevy CB; Holt J; Buniak B
    J Assoc Acad Minor Phys; 1993; 4(1):30-2. PubMed ID: 8425102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of primary biliary cirrhosis with cyclosporin. A report on 2 cases].
    Crespo Rincón L; Medina Asensio J; Casinello Ogea C; Riopérez Carmena E
    Rev Clin Esp; 1991 Jan; 188(1):55-6. PubMed ID: 2063033
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of cyclosporine and cyclosporine plus prednisone in primary biliary cirrhosis.
    Beukers R; Schalm SW
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):340-3. PubMed ID: 3381295
    [No Abstract]   [Full Text] [Related]  

  • 13. Is bezafibrate histologically effective for primary biliary cirrhosis?
    Yano K; Kato H; Morita S; Takahara O; Ishibashi H; Furukawa R
    Am J Gastroenterol; 2002 Apr; 97(4):1075-7. PubMed ID: 12003404
    [No Abstract]   [Full Text] [Related]  

  • 14. [Primary biliary cirrhosis. Clinico-semeiological findings].
    Surrenti C; Salvadori G; Casini A; Amadori A; Buzzelle G; Laffi G; Agostino I; Gentilini P
    Recenti Prog Med; 1977 Sep; 63(3):228-57. PubMed ID: 579473
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of primary biliary cirrhosis with ursodeoxycholic acid].
    Lotterer E; Fleig WE
    Z Gastroenterol; 1993 Oct; 31(10):633-5. PubMed ID: 8256481
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases.
    Ballot E; Bandin O; Chazouilleres O; Johanet C; Poupon R
    J Autoimmun; 2004 Mar; 22(2):153-8. PubMed ID: 14987744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of the overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis: retrospective study.
    Wu CH; Wang QH; Tian GS; Xu XY; Yu YY; Wang GQ
    Chin Med J (Engl); 2006 Feb; 119(3):238-41. PubMed ID: 16537013
    [No Abstract]   [Full Text] [Related]  

  • 18. High incidence of poor sulfoxidation in patients with primary biliary cirrhosis.
    Olomu AB; Vickers CR; Waring RH; Clements D; Babbs C; Warnes TW; Elias E
    N Engl J Med; 1988 Apr; 318(17):1089-92. PubMed ID: 3281015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
    Lampe K; Hüdepohl M; Schopen RD
    Med Klin; 1972 Apr; 67(15):527-34. PubMed ID: 5053009
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary biliary cirrhosis (PBC): is effective therapy now at hand?
    Kaplan MM; Knox TA; Arora S
    Trans Assoc Am Physicians; 1988; 101():193-202. PubMed ID: 3269678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.